FormWeb
 
Check out the 2019 Prisma Health-Midlands' Antibiograms!
IDSA Antimicrobial Stewardship
Centers of Excellence Designation
PHASST: 
Prisma Health-Midlands Antimicrobial Stewardship and Support Team

PHASST Members
Meet the 2018 PHASST Members
Pictured (left to right): Front Row - Mariam Younas, MD; Hana Rac, Pharm.D.; Julie Justo, Pharm.D.; Caroline Derrick, Pharm.D.
Back Row - Joseph Kohn, Pharm.D.; Emily Haggard, Pharm.D.; Majdi Al-Hasan, MD; Krutika Mediwala, Pharm.D.; Casey Troficanto, Pharm.D.;
Brandon Bookstaver, Pharm.D.

 PH Antimicrobial Guidebook  Antibiograms
Columbia Physician Orders
2018 Guidebook PH Detailed Antibiograms 2019 PowerPlans
Hot Topics in the Literature
 PH Stewardship Paper of the Year

2018: 
Early de-escalation of therapy reduces risk of C. difficile infection

Primary Author: Megan Seddon, PharmD

2017:
Antimicrobial stewardship and rapid diagnostics partnership for bloodstream infections

Primary Author: Brandon Bookstaver, PharmD, FCCP,                        
FIDSA, BCPS

2016:                 
Effectiveness of oral antibiotics for definitive         
therapy of Gram-negative bloodstream infections
           
Primary Author:
 Leila Kutob,MD

2015:
Antibiotics save lives, when lives are on the line

Primary Author: Sarah Battle, MD

Optimizing Empirical Therapy

1. Antibiotics save lives, when lives are on the
    line

2. Appropriate antibiotics also send patients
    home sooner

3. Who needs empirical antipseudomonal
    therapy

4What about chromosomally-mediated AmpC-          producing Enterobacteriaceae?

5. When should we use empirical carbapenems           for high risk of ESBLs?

6Who should receive empirical
    fluoroquinolones?

7. Management of acute pyelonephritis in                   outpatient settings

8. Improving care while using less broad-spectrum     antibiotics

All You Need to Know About Bloodstream Infections (BSI)

1. BSI is the 7th leading cause of death in the
    U.S. 

2Management of BSI, a surgical approach

3. Management of Staphylococcus aureus BSI

4. Six steps to improve outcome of patients with   
    S.aureus BSI

5. Can we use oral antibiotics for gram-negative
    BSI?


6. Defining prognosis of a patient with BSI using the        Bloodstream Infection Mortality Risk Score (BSIMRS)

7. The heavy cost of fluoroquinolone resistance

8. Optimize, do not minimize

Guidelines 
Reference Tools PHASST Year in Review
Acute Cystitis and Pyelonephritis - Adult INPATIENT Management 

Acute Cystitis and Pyelonephritis - Adult OUTPATIENT Management 

Acute Sinusitis - Adult OUTPATIENT Management

Antihelminthic Treatment Guidelines

Antimicrobial Lock Therapy Guidelines

Clostridium difficile Testing Algorithm

Clostridium difficile Infection(CDI) Management in Adults

ESBL Prediction Score

Fluoroquinolone Resistance Prediction Score

Guidelines for Gram Negative Bloodstream Infections

Intraabdominal Infection (IAI) Guidelines In Hospitalized Adults

Management of S. aureus bloodstream infections

Neutropenic Fever Treatment & De-escalation Guideline

Open Fractures' Antibiotic Prophylaxis Guideline

Pneumonia Guidelines

Pseudomonas Prediction Score

Skin and Soft Tissue Infection (SSTI) in Hospitalized Adults

2017 Vancomycin Dosing Guidelines (Adult)

General Vancomycin Use Guidelines

Aminoglycosides, Extended Interval Dosing

Antimicrobial Lock Recipes 

Antimicrobial Stewardship Order Entry Process

Antiretroviral Quick Guide

Carbapenem Resistance

Clincalc for Vancomycin

Continuous Infusion Antibiotics - Standard Concentrations

FAQ: Clostridium difficile Infection

FAQ: FilmArray Blood Culture ID (BCID) Panel

HAART Crushable Medications

HAART Recommended Combinations

Polymyxin Use Guidelines

Preferred Formulary Agents for MRSA

SCIP Antibiotic Selection 2015

Telavancin (Vibativ) injection information
- 2015

- 2016

- 2017

- 2018

 

Pediatrics Antimicrobial Stewardship Program
Webpage Link

 

 

 

 

 

 

 

 

 

 

 

 

 






This site is intended for the staff of Prisma Health-Midlands.
While others may view accessible pages, Prisma Health-Midlands makes no warranted, expressed or implied,
use of this information outside of Prisma Health-Midlands.